Klingman & Associates’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
Other funds holding NRC
CCA
ACM
Klingman & Associates's NRC Position: Q2 2021 in Review
Klingman & Associates sold out of NRC Health Common Stock (NRC) in Q2 2021, closing a stake of 7,000 shares — an estimated $328K sold.
Klingman & Associates first reported a position in NRC in Q4 2020 and held it in 2 quarters. The position peaked at $328K in Q1 2021. 100 funds tracked by Wall St. Rank hold NRC as of Q2 2021.
- Klingman & Associates reported no remaining NRC Health Common Stock position as of Q2 2021 after selling out during the quarter.
- Klingman & Associates sold 7,000 NRC Health Common Stock shares in Q2 2021, an estimated $328K.
- Klingman & Associates first reported a position in NRC Health Common Stock in Q4 2020 and held it in 2 quarters.
- Klingman & Associates's NRC Health Common Stock position peaked at $328K in Q1 2021.
- 100 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2021.
Based on Klingman & Associates's 13F filing for Q2 2021, filed 27 Jul 2021.